Human TGF-beta RII ELISA Kit (Colorimetric)
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-60148
Key Product Details
Sample Type & Volume Required Per Well
Serum, plasma and tissue homogenates (50 - 100 uL)
Sensitivity
3.9 pg/mL
Assay Range
15.6 pg/mL - 1000 pg/mL
Product Specifications
Assay Type
Sandwich ELISA
Kit Type
ELISA Kit (Colorimetric)
Reactivity
Human
Specificity
This assay has high sensitivity and excellent specificity for detection of human TGF-BR2. No significant cross-reactivity or interference between human TGF-BR2 and analogues was observed.
Description
Assay Length: 1-5 hours
Precision
Intra-Assay Precision (Precision within an assay) %CV < 8
Inter-Assay Precision (Precision between assays) %CV < 10
Scientific Data Images for Human TGF-beta RII ELISA Kit (Colorimetric)
Human TGF-beta RII ELISA Kit (Colorimetric) [NBP2-60148] -
Human TGF-beta RII ELISA Kit (Colorimetric) [NBP2-60148] - Standard Curve ReferenceKit Contents for Human TGF-beta RII ELISA Kit (Colorimetric)
- Adhesive Strip (For 96 wells)
- Assay plate (12 x 8 coated Microwells)
- Biotin-antibody (100 x concentrate)
- Biotin-antibody Diluent
- HRP-avidin (100 x concentrate)
- HRP-avidin Diluent
- Instruction manual
- Sample Diluent
- Standard (Freeze dried)
- Stop Solution
- TMB Substrate
- Wash Buffer (25 x concentrate)
Preparation and Storage
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Storage of components varies. See protocol for specific instructions.
Background: TGF-beta RII
Long Name
Transforming Growth Factor beta Receptor II
Alternate Names
TGF-bRII, TGFbetaRII, TGFBR2
Gene Symbol
TGFBR2
Additional TGF-beta RII Products
Product Documents for Human TGF-beta RII ELISA Kit (Colorimetric)
Product Specific Notices for Human TGF-beta RII ELISA Kit (Colorimetric)
This product is for research use only and is not approved for use in humans or in clinical diagnosis. ELISA Kits are guaranteed for 6 months from date of receipt.
Loading...
Loading...
Loading...
Loading...